VIVEVE MED INC - COM NEW (VIVE)

CUSIP: 92852W204

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM NEW
Total 13F shares
11,756,518
Share change
+6,132,634
Total reported value
$74,311,000
Price per share
$6.33
Number of holders
21
Value change
+$38,789,713
Number of buys
19
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 92852W204?
CUSIP 92852W204 identifies VIVE - VIVEVE MED INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of VIVEVE MED INC - COM NEW (VIVE) as of Q1 2017

As of 31 Mar 2017, VIVEVE MED INC - COM NEW (VIVE) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,756,518 shares. The largest 10 holders included Stonepine Capital Management, LLC, HighTower Advisors, LLC, RTW INVESTMENTS, LP, ACUTA CAPITAL PARTNERS, LLC, PERCEPTIVE ADVISORS LLC, venBio Select Advisor LLC, Wexford Capital LP, GRANAHAN INVESTMENT MANAGEMENT INC/MA, Alyeska Investment Group, L.P., and EcoR1 Capital, LLC. This page lists 21 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.